Related references
Note: Only part of the references are listed.Cancer statistics, 2023
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2023)
Impact on quality of life from multimodality treatment for lung cancer: a randomised controlled feasibility trial of surgery versus no surgery as part of multimodality treatment in potentially resectable stage III-N2 NSCLC (the PIONEER trial)
Sally Taylor et al.
BMJ OPEN RESPIRATORY RESEARCH (2021)
A large real-world cohort study of examined lymph node standards for adequate nodal staging in early non-small cell lung cancer
Zhihua Zhu et al.
TRANSLATIONAL LUNG CANCER RESEARCH (2021)
Advances in systemic therapy for non-small cell lung cancer
Meagan Miller et al.
BMJ-BRITISH MEDICAL JOURNAL (2021)
Kaplan-Meier Curves, Log-Rank Tests, and Cox Regression for Time-to-Event Data
Patrick Schober et al.
ANESTHESIA AND ANALGESIA (2021)
Application of N Descriptors Proposed by the International Association for the Study of Lung Cancer in Clinical Staging
Hwayoung Song et al.
RADIOLOGY (2021)
Tumor size as a predictor for prognosis of patients with surgical IIIA-N2 non-small cell lung cancer after surgery
Kunpeng Zhang et al.
JOURNAL OF THORACIC DISEASE (2021)
Survival benefit of skip metastases in surgically resected N2 non-small cell lung cancer: A multicenter observational study of a large cohort of the Chinese patients
Xin Li et al.
EJSO (2020)
Association Between Lymph Node Ratio and Survival in Patients with Pathological Stage II/III Gastric Cancer
Kazuki Kano et al.
ANNALS OF SURGICAL ONCOLOGY (2020)
Prognostic Value of Tumor Size in Resected Stage IIIA-N2 Non-Small-Cell Lung Cancer
Chih-Yu Chen et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Prognostic value of log odds of positive lymph nodes in patients with resectable oral squamous cell carcinoma
Wanyong Jin et al.
ORAL ONCOLOGY (2020)
Lymph-node ratio predicts survival among the different stages of non-small-cell lung cancer: a multicentre analysis
Marco Chiappetta et al.
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY (2019)
Lymph node ratio (LNR) as a complementary staging system to TNM staging in salivary gland cancer
Bo-Wen Lei et al.
EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY (2019)
Recommended Change in the N Descriptor Proposed by the International Association for the Study of Lung Cancer: A Validation Study
Byung Jo Park et al.
JOURNAL OF THORACIC ONCOLOGY (2019)
Asymptotics of AIC, BIC, and RMSEA for Model Selection in Structural Equation Modeling
Po-Hsien Huang
PSYCHOMETRIKA (2017)
The Eighth Edition Lung Cancer Stage Classification
Frank C. Detterbeck et al.
CHEST (2017)
Time to refine N2 staging? cN2α and cN2β based on local regional involvement provide a more accurate prognosis in surgically treated IIIA non-small-cell lung cancer than N2 alone or the number of node stations involved
Takeshi Matsunaga et al.
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY (2014)
Lymph Node Ratio Predicts Recurrence and Survival After R0 Resection for Non-Small Cell Lung Cancer
Matthew D. Taylor et al.
ANNALS OF THORACIC SURGERY (2013)
The Prognostic Value of Ratio-Based Lymph Node Staging in Resected Non-Small-Cell Lung Cancer
Chen Qiu et al.
JOURNAL OF THORACIC ONCOLOGY (2013)
Clinicopathological factors associated with unexpected N3 in patients with mediastinal lymph node involvement
Yukinori Sakao et al.
JOURNAL OF THORACIC ONCOLOGY (2007)
X-tile: A new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization
RL Camp et al.
CLINICAL CANCER RESEARCH (2004)
Share Paper
